Dr. Harrold is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Department Of Rheumatology
Worcester, MA 01655Phone+1 508-334-5224
Education & Training
- UMass Chan Medical SchoolFellowship, Rheumatology, 1995 - 1998
- UMass Chan Medical SchoolResidency, Internal Medicine, 1992 - 1995
- University of Massachusetts Medical SchoolClass of 1992
Certifications & Licensure
- MA State Medical License 1997 - 2020
- CT State Medical License Active through 2013
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 409 citations2020 American College of Rheumatology Guideline for the Management of Gout.John D FitzGerald, Nicola Dalbeth, Ted Mikuls, Romina Brignardello-Petersen, Gordon Guyatt
Arthritis & Rheumatology. 2020-06-01 - 37 citationsUnmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry DermatologistsBruce Strober, Nirali Kotowsky, Rose A. Medeiros, Rachel H. Mackey, Leslie R. Harrold
Dermatology and Therapy. 2021-02-27 - 266 citationsThe incidence of adverse drug events in two large academic long-term care facilitiesJerry H. Gurwitz, Terry S. Field, James O. Judge, Paula A. Rochon, Leslie R. Harrold
The American Journal of Medicine. 2005-03-01
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationLeslie Harrold, MD, Oxford University Press
Press Mentions
- Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic DiseasesNovember 3rd, 2021
- Treatment Failing Majority of RA PatientsNovember 27th, 2019
- Bristol-Myers Squibb Underscores Precision-Focused Immunology Leadership with New Data on ORENCIA® (Abatacept) in Early RA, ACPA-Positive Patients Presented at 2019 ACR/ARP Annual Meeting1November 7th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: